The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled.

Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-00536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Borrower representation for loan to Goldsboro Milling Company
Represented Goldsboro Milling Company in securing a $187 million loan from multiple lenders secured by personal and real property in multiple states. more
Patent and trademark portfolio management for Oldcastle Inc.
Represented Oldcastle Inc. in comprehensive patent and trademark portfolio management, including counsel and administration relative to more
EyeWonder, Inc. v. John Abraham
The firm served as lead counsel for EyeWonder, Inc. in the Southern District of New York to enforce restrictive covenants when its former head of more
Trademark infringement for a large American retail company
Assisted large American retail company in investigating and pursuing trademark infringement in Asia, including potential criminal and civil remedies. more